Hereditary Angioedema Therapeutics - Pipeline Assessment and Market Forecasts to 2019 On 27thNovember 2014
Summary The industry analysis specialist, has released its new report, “Hereditary Angioedema Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global Hereditary Angioedema Therapeutics market. The report identifies the key trends shaping and driving the global Hereditary Angioedema Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Hereditary Angioedema Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
You can buy this Report @ http://www.jsbmarketresearch.com/healthcaremedical/r-hereditary-angioedema-therapeutics-pipeline-assessment-andmarket-forecasts-135224 Scope The report provides information on the key drivers and challenges of the Hereditary Angioedema Therapeutics market. Its scope includes Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Hereditary Angioedema Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019. - Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes. - Analysis of the current and future competition in the seven key countries Hereditary Angioedema Therapeutics market. - Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. - Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Hereditary Angioedema Therapeutics market. - Analysis of key recent licensing and partnership agreements in Hereditary Angioedema Therapeutics market
Reasons to buy The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the global Hereditary Angioedema Therapeutics market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Hereditary Angioedema Therapeutics market in future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
- What’s the next big thing in the global Hereditary Angioedema Therapeutics market landscape? – Identify, understand and capitalize.
Other industries we cover: • • • • • • • • •
Advertising and Media Automotive and Parts Consumer Goods Healthcare and Medical Finance and Banking Food and Beverages Travel and Tourism Textiles and Clothing SWOT Analysis
Discounts on Market Research Reports till 31st December, 2014 For more inquiries, contact at +91 - 998 729 5242 / contact@jsbmarketresearch.com Table of Content 2 Hereditary Angioedema Therapeutics - Introduction 2.1 Disease Overview 2.1.1 Types of Hereditary Angioedema 2.2 Epidemiology 2.2.1 Prevalence 2.2.2 Mortality/Morbidity 2.2.3 Quality of Life 2.2.4 Pharmaco-economic Burden 2.3 Etiology and Pathophysiology 2.4 Signs and Symptoms 2.4.1 Symptoms before an Attack 2.4.2 Symptoms during the Attack 2.5 Diagnosis 2.5.1 Primary Clinical Assessment 2.5.2 Laboratory Tests Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
2.5.3 Hereditary Angioedema is Under-Diagnosed 2.6 Treatment and Management Options 2.6.1 Treatment of Acute Attacks 2.6.2 Short-Term Prophylactic Treatment 2.6.3 Long-Term Prophylactic Treatment 2.7 Referral Pathway 2.8 GlobalData Pipeline Report Guidance 3 Hereditary Angioedema Therapeutics - Market Characterization 3.1 Hereditary Angioedema Therapeutics Market Size (2006-2011) - Global 3.2 Hereditary Angioedema Therapeutics Market Forecast (2011-2019) - Global 3.3 Hereditary Angioedema Therapeutics Market Size (2006-2011) - The US 3.4 Hereditary Angioedema Therapeutics Market Forecast (2011-2019) - The US 3.5 Hereditary Angioedema Therapeutics Market Size (2006-2011) - France 3.6 Hereditary Angioedema Therapeutics Market Forecast (2011-2019) - France 3.7 Hereditary Angioedema Therapeutics Market Size (2006-2011) - Germany 3.8 Hereditary Angioedema Therapeutics Market Forecast (2011-2019) - Germany 3.9 Hereditary Angioedema Therapeutics Market Size (2006-2011) - Italy 3.10 Hereditary Angioedema Therapeutics Market Forecast (2011-2019) - Italy 3.11 Hereditary Angioedema Therapeutics Market Size (2006-2011) - Spain 3.12 Hereditary Angioedema Therapeutics Market Forecast (2011-2019) - Spain 3.13 Hereditary Angioedema Therapeutics Market Size (2006-2011) - The UK 3.14 Hereditary Angioedema Therapeutics Market Forecast (2011-2019) - The UK 3.15 Hereditary Angioedema Therapeutics Market Size (2006-2011) - Japan 3.16 Hereditary Angioedema Therapeutics Market Forecast (2011-2019) - Japan 3.17 Drivers and Barriers for the Hereditary Angioedema Therapeutics Market 3.17.1 Drivers for the Hereditary Angioedema Therapeutics Market 3.17.2 Barriers to the Hereditary Angioedema Therapeutics Market 3.18 Opportunity and Unmet Need Analysis 3.19 Key Takeaway 4 Hereditary Angioedema Therapeutics - Competitive Assessment 4.1 Overview 4.2 Strategic Competitor Assessment 4.3 Product Profiles for the Major Marketed Products in the Hereditary Angioedema Therapeutics Market 4.3.1 Berinert [C1 Esterase Inhibitor (Human)] 4.3.2 Cinryze (C1 Esterase Inhibitor [Human]) 4.3.3 Firazyr (icatibant) 4.3.4 Kalbitor (ecallantide) 4.3.5 Ruconest/Rhucin (conestat alfa) Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
4.4 Key Takeaway 5 Hereditary Angioedema Therapeutics - Pipeline Assessment 5.1 Overview 5.2 Strategic Pipeline Assessment 5.3 Hereditary Angioedema Therapeutics Pipeline - Pipeline by Phase of Development 5.3.1 Hereditary Angioedema Therapeutics - Phase III Pipeline 5.3.2 Hereditary Angioedema Therapeutics - Phase II/III Pipeline 5.3.3 Hereditary Angioedema Therapeutics - Phase II Pipeline 5.3.4 Hereditary Angioedema Market - Pre-Clinical Pipeline 5.3.5 Technology Trends Analytic Framework 5.4 Hereditary Angioedema Therapeutics Market - Clinical Pipeline by Mechanism of Action 5.5 Hereditary Angioedema Therapeutics - Promising Drugs Under Clinical Development 5.6 Key Takeaway 6 Hereditary Angioedema Therapeutics - Clinical Trials Mapping 6.1 Clinical Trials by Region/Country (The US, EU5 and Japan) 6.2 Clinical Trials by Phase 6.3 Clinical Trials by Trial Status 6.4 Prominent Sponsors 6.5 Top Companies Participating in Hereditary Angioedema Therapeutics Clinical Trials 7 Strategic Assessment 7.1 Key Events Impacting the Future Market 7.2 Hereditary Angioedema Therapeutics - Implications for Future Market Competition 8 Hereditary Angioedema Therapeutics - Future Players 8.1 Introduction 8.2 Company Profiles 8.2.1 Pharming 8.2.2 Dyax Corp 8.2.3 ViroPharma 8.2.4 BioCryst Pharmaceuticals, Inc. 9 Hereditary Angioedema Therapeutics - Licensing and Partnership Deals 10 Hereditary Angioedema Therapeutics - Appendix 10.1 Market Definitions 10.2 Abbreviations 10.3 Methodology 10.3.1 Coverage 10.3.2 Secondary Research 10.3.3 Forecasting 10.3.4 Primary Research 10.3.5 Expert Panel Validation Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
10.4 Contact Us 10.5 Disclaimer 10.6 Bibliography
List Of Tables Table 1: Hereditary Angioedema Therapeutics - Quality of Life Table 2: Hereditary Angioedema Therapeutics - Symptoms during the Attack Table 3: Hereditary Angioedema Therapeutics Market, Global, Revenue ($m), 2006-2011 Table 4: Hereditary Angioedema Therapeutics Market, Global, Forecasts ($m), 2011-2019 Table 5: Hereditary Angioedema Therapeutics Market, The US, Revenue ($m), 2006-2011 Table 6: Hereditary Angioedema Therapeutics Market, The US, Forecasts ($m), 2011-2019 Table 7: Hereditary Angioedema Therapeutics Market, France, Revenue ($m), 2006-2011 Table 8: Hereditary Angioedema Therapeutics Market, France, Forecasts ($m), 2011-2019 Table 9: Hereditary Angioedema Therapeutics Market, Germany, Revenue ($m), 2006-2011 Table 10: Hereditary Angioedema Therapeutics Market, Germany, Forecasts ($m), 2011-2019 Table 11: Hereditary Angioedema Therapeutics Market, Italy, Revenue ($m), 2006-2011 Table 12: Hereditary Angioedema Therapeutics Market, Italy, Forecasts ($m), 2011-2019 Table 13: Hereditary Angioedema Therapeutics Market, Spain, Revenue ($m), 2006-2011 Table 14: Hereditary Angioedema Therapeutics Market, Spain, Forecasts ($m), 2011-2019 Table 15: Hereditary Angioedema Therapeutics Market, The UK, Revenue ($m), 2006-2011 Table 16: Hereditary Angioedema Therapeutics Market, The UK, Forecasts ($m), 2011-2019 Table 17: Hereditary Angioedema Therapeutics Market, Japan, Revenue ($m), 2006-2011 Table 18: Hereditary Angioedema Therapeutics Market, Japan, Forecasts ($m), 2011-2019 Table 19: Hereditary Angioedema Therapeutics - Adverse Events Related to Berinert Table 20: Hereditary Angioedema Therapeutics - Number of Hereditary Angioedema Attacks Table 21: Hereditary Angioedema Therapeutics - Efficacy of Cinryze Table 22: Hereditary Angioedema Therapeutics - Adverse Reactions in Routine Prophylaxis Study LEVP2005-1/B Table 23: Hereditary Angioedema Therapeutics - Efficacy of Firazyr Table 24: Hereditary Angioedema Therapeutics - Adverse Reactions Associated with Firazyr Table 25: Hereditary Angioedema Therapeutics - Efficacy of Kalbitor Table 26: Hereditary Angioedema Therapeutics - Adverse Reactions Associated with Kalbitor Table 27: Hereditary Angioedema Therapeutics - Efficacy of Ruconest Table 28: Hereditary Angioedema Therapeutics, Phase III Pipeline, 2011 Table 29: Hereditary Angioedema Therapeutics, Phase II/III Pipeline, 2011 Table 30: Hereditary Angioedema Therapeutics, Phase II Pipeline, 2011 Table 31: Hereditary Angioedema Therapeutics, Pre-Clinical Pipeline, 2011 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Table 32: Hereditary Angioedema Therapeutics, Clinical Trials by Country, 2011 Table 33: Hereditary Angioedema Therapeutics, Clinical Trials by Phase, 2011 Table 34: Hereditary Angioedema Therapeutics, Clinical Trials by Status (%), 2011 Table 35: Hereditary Angioedema Therapeutics, Prominent Sponsors, 2011 Table 36: Hereditary Angioedema Therapeutics, Top Companies Participating in Clinical Trials, 2011 Table 37: Pharming, Immunology Pipeline, 2011 Table 38: Dyax, Immunology Pipeline, 2011 Table 39: ViroPharma, Immunology Pipeline, 2011 Table 40: BioCryst, Immunology Pipeline, 2011 Table 41: Hereditary Angioedema Therapeutics, Global, Deals, 2009-2011
List Of Figures Figure 1: Hereditary Angioedema Therapeutics - Types of Hereditary Angioedema Figure 2: Hereditary Angioedema Therapeutics - Pathophysiology Figure 3: Hereditary Angioedema Therapeutics - Pathophysiology Figure 4: Hereditary Angioedema Therapeutics - Laboratory Evaluation for Hereditary Angioedema Figure 5: Hereditary Angioedema Therapeutics - Diagnosis of Hereditary Angioedema Figure 6: Hereditary Angioedema Therapeutics - Physician Knowledge as Rated by Respondents Figure 7: Hereditary Angioedema Therapeutics - FDA Approved Therapies for Hereditary Angioedema Figure 8: Hereditary Angioedema Therapeutics - Referral Pathway Figure 9: Hereditary Angioedema Therapeutics Market, Global, Revenue ($m), 2006-2011 Figure 10: Hereditary Angioedema Therapeutics Market, Global, Forecast ($m), 2011-2019 Figure 11: Hereditary Angioedema Therapeutics Market, The US, Revenue ($m), 2006-2011 Figure 12: Hereditary Angioedema Therapeutics Market, The US, Forecast ($m), 2011-2019 Figure 13: Hereditary Angioedema Therapeutics Market, France, Revenue ($m), 2006-2011 Figure 14: Hereditary Angioedema Therapeutics Market, France, Forecast ($m), 2011-2019 Figure 15: Hereditary Angioedema Therapeutics Market, Germany, Revenue ($m), 2006-2011 Figure 16: Hereditary Angioedema Therapeutics Market, Germany, Forecast ($m), 2011-2019 Figure 17: Hereditary Angioedema Therapeutics Market, Italy, Revenue ($m), 2006-2011 Figure 18: Hereditary Angioedema Therapeutics Market, Italy, Forecast ($m), 2011-2019 Figure 19: Hereditary Angioedema Therapeutics Market, Spain, Revenue ($m), 2006-2011 Figure 20: Hereditary Angioedema Therapeutics Market, Spain, Forecast ($m), 2011-2019 Figure 21: Hereditary Angioedema Therapeutics Market, The UK, Revenue ($m), 2006-2011 Figure 22: Hereditary Angioedema Therapeutics Market, The UK, Forecast ($m), 2011-2019 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Figure 23: Hereditary Angioedema Therapeutics Market, Japan, Revenue ($m), 2006-2011 Figure 24: Hereditary Angioedema Therapeutics Market, Japan, Forecast ($m), 2011-2019 Figure 25: Hereditary Angioedema Therapeutics - Strategic Competitor Assessment, 2010 Figure 26: Hereditary Angioedema Therapeutics - Time to Onset of Symptom Relief Figure 27: Hereditary Angioedema Therapeutics - Pipeline by Phase of Development, 2011 Figure 28: Hereditary Angioedema Therapeutics, Technology Trends Analytics Framework, 2011 Figure 29: Hereditary Angioedema Therapeutics, Technology Trends Analytics Framework, Description, 2011 Figure 30: Hereditary Angioedema Therapeutics, Pipeline by Mechanism of Action (%), 2011 Figure 31: Hereditary Angioedema Therapeutics, Clinical Trials by Phase (%), 2011 Figure 32: Hereditary Angioedema Therapeutics, Clinical Trials by Status (%), 2011 Figure 33: Hereditary Angioedema Therapeutics, Prominent Sponsors (%), 2011 Figure 34: Hereditary Angioedema Therapeutics, Top Companies Participating in Clinical Trials, 2011 Figure 35: Hereditary Angioedema Therapeutics Market, Drivers and Restraints, 2011 Figure 36: Implications for Future Market Competition in the Hereditary Angioedema Market, 2011 Figure 37: Hereditary Angioedema Therapeutics Market, Pipeline by Company, 2011 Figure 38: GlobalData Market Forecasting Model
Report Price: Licence Type
Price
$ 3995
Site Licence
$ 7990
Enterprise Wide Licence
$ 11985
Related Reports: Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Aplastic Anemia Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Polycythemia Vera Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Polycystic Kidney Disease (PKD) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Social Anxiety Disorders (SAD) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Psychotic Depression Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Panic Disorder Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Tourette Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Myasthenia Gravis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Infantile Spasms Therapeutics - Pipeline Assessment and Market Forecasts to 2019
You can order this report by calling on +91 - 998 7295 242 or mail us your contact details at contact@jsbmarketresearch.com About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along with providing in-depth analysis though reports, JSB market research also provides regular updates of the market though newsletters. Our reports are a well-researched work of market researchers with an extensive knowledge and a good level of market experience.
To know more on Hereditary Angioedema Therapeutics - Pipeline Assessment and Market Forecasts to 2019 http://www.jsbmarketresearch.com/healthcare-medical/r-hereditaryangioedema-therapeutics-pipeline-assessment-and-market-forecasts-135224
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/